Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
RYTM compared with EWTX: revenue, margins and what each company keeps, and the suppliers and customers both name
RYTM
Rhythm Pharmaceuticals, Inc.
Change
Mkt cap
Revenue
Revenue
EWTX
Edgewise Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
RYTM
Rhythm Pharmaceuticals, Inc.
vs
EWTX
Edgewise Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
RYTM, solid
EWTX, dashed
Supply-chain overlap
Revenue flow
RYTM: latest quarter is a loss; flow not drawable. EWTX: latest quarter not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only RYTM
10
—
Camurus AB
unlisted
supplier
—
CGC Genetics Unilabs
unlisted
supplier
—
Ipsen
unlisted
supplier
—
LG Chem
unlisted
supplier
6 more · RYTM chain
›
Shared
0
No shared counterparties.
Only EWTX
2
—
Leerink
unlisted
supplier
—
Silicon Valley Bank (SVB)
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
RYTM
Rhythm Pharmaceuticals, Inc.
Change
91.74
▼
−1.43%
· post 91.74
Mkt cap
$6.4B
Revenue
$71M
Q2 FY26
Revenue
$190M
FY25
EWTX
Edgewise Therapeutics, Inc.
Change
38.93
▲
+0.04%
· post 39.06
Closed
Oct 30 '26
Mkt cap
$4.2B
Revenue
—
Revenue
—
vs
Compare
Closed
Oct 30 '26
RYTM
Rhythm Pharmaceuticals, Inc.
vs
EWTX
Edgewise Therapeutics, Inc.
91.74
▼
−1.43%
post 91.74
Price
38.93
▲
+0.04%
post 39.06
$6.4B
Mkt cap
$4.2B
Q2 FY26
$71M
Revenue
—
FY25
$190M
Revenue
—
Change
Change
RYTM
91.74
▼
−1.43%
vs
EWTX
38.93
▲
+0.04%
Closed
Oct 30 '26